{"meshTags":["Antineoplastic Agents","Antineoplastic Combined Chemotherapy Protocols","Chemotherapy, Adjuvant","Humans","Immunotherapy","Lymph Node Excision","Melanoma","Neoplasm Staging","Palliative Care","Prognosis","Radiotherapy, Adjuvant","Skin Neoplasms"],"meshMinor":["Antineoplastic Agents","Antineoplastic Combined Chemotherapy Protocols","Chemotherapy, Adjuvant","Humans","Immunotherapy","Lymph Node Excision","Melanoma","Neoplasm Staging","Palliative Care","Prognosis","Radiotherapy, Adjuvant","Skin Neoplasms"],"publicationTypes":["English Abstract","Journal Article"],"abstract":"Skin melanoma is one of the rare cancers whose prevalence has increased over the past decades. Its treatment is based on a classification into four anatomoclinical stages. Surgical excision is the mainstay of therapy. However, several protocols of chemotherapy, radiotherapy and immunotherapy also have specific indications in the therapeutic or palliative approach to the disease.","title":"[Drug clinics. How I treat cutaneous melanoma].","pubmedId":"9555173"}